Medication info

Glimepil Tablet (Glimperide)

Prescription medicationTabletOralCompany closed
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Doceo. Co., Ltd.
Appearance
Yellow oval-shaped tablets
Packaging
100 tablets (PTP)
Approval status
Company closed

MFDS item code 201306839 · Approved 2013.04.10

This product's status changed to Company closed on 2024.04.09. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 glass of water. This drug is administered orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional benefit at doses over 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered when weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral antihyperglycemic agent to this drug There is no exact dose equivalence between this drug and other oral antihyperglycemic agents. When switching from another oral antihyperglycemic agent to this drug, it is recommended to follow the instructions provided under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered drug. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this drug and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dose adjustment at regular intervals is necessary while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If a patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. With combination therapy of this drug and metformin, the target blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this drug and metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Importer
Doceo. Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Impairment of blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to assist in blood sugar control for patients with type 2 diabetes. It can be taken alone alongside dietary and exercise regimens, and if blood sugar control is insufficient, it can be combined with other antihyperglycemic agents or insulin. Particularly, this medication is more effective in blood sugar control when combined with sulfonylureas or when treatment with metformin alone is inadequate. This medication is effectively used for blood sugar management in patients with type 2 diabetes.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 glass of water. This drug is administered orally once daily. Take this drug before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this drug. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional benefit at doses over 4 mg, although some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this drug may decrease. Therefore, dose reduction or discontinuation of this drug may be necessary to avoid hypoglycemia. Dose adjustment should also be considered when weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral antihyperglycemic agent to this drug There is no exact dose equivalence between this drug and other oral antihyperglycemic agents. When switching from another oral antihyperglycemic agent to this drug, it is recommended to follow the instructions provided under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the potency and duration of action of the previously administered drug. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this drug and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this drug once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Insulin dose adjustment at regular intervals is necessary while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If a patient does not respond adequately to the maximum dose of this drug, addition of metformin may be considered. With combination therapy of this drug and metformin, the target blood glucose level may be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this drug and metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent diabetes or severe hepatic and renal dysfunction. It should not be taken by women who are pregnant or breastfeeding, and insulin therapy is preferable for patients with severe infections or around surgical procedures. Patients with lactose intolerance or specific genetic metabolic disorders should also refrain from using this medication. During the first week of administration, there is a heightened risk of hypoglycemia; thus, blood sugar levels should be closely monitored, particularly in elderly patients, those with poor nutritional status, those with irregular eating habits, or those with weakened renal or hepatic function. Symptoms of hypoglycemia include headache, severe hunger, nausea, fatigue, confusion, drowsiness, and decreased consciousness, and if any of these symptoms occur, sugar should be consumed immediately. This medication may affect the liver or blood, so if symptoms of liver dysfunction or blood abnormalities appear, a consultation with a physician is necessary. Allergic reactions such as urticaria, rash, or difficulty breathing may occur, and if such symptoms arise, discontinue use and inform healthcare professionals immediately. During treatment with this medication, it is crucial to maintain a consistent diet and exercise regimen and to regularly check blood sugar levels. Interactions may occur when taking other medications, so inform healthcare professionals of all medications currently being taken and proceed with caution. Overdose may lead to severe hypoglycemia, so if suspected, immediate emergency care and hospital visits are necessary. Store this medication out of reach of children and in its original container for safe storage.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, language disorders, aphasia, visual impairment, tremors, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, transient mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and moist skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, hence, it must be stored in a tightly sealed container. Additionally, it is best to store at room temperature between 1°C and 30°C. Proper storage will maintain the medication's efficacy for a longer duration.

Appearance and packaging

Appearance

Yellow oval-shaped tablets

Package unit

100 tablets (PTP)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.